POSTN expressed in cancer-associated fibroblasts or other stromal cells may facilitate the aggressiveness of pancreatic cancer, ovarian cancer, prostate cancer, esophageal adenocarcinoma, gastric cancer, breast cancer, and cholangiocarcinoma [13–19]. This evidence concerns the gene POSTN and esophageal adenocarcinoma.